Pubblicazioni

Autori:

Pesarini, Gabriele; Lunardi, Mattia; Piccoli, Anna; Gottin, Leonardo; Prati, Daniele; Ferrero, Valeria; Scarsini, Roberto; Milano, Aldo; Forni, Alberto; Faggian, Giuseppe; Ribichini, Flavio

Titolo:

Effectiveness and Safety of Transcatheter Aortic Valve Implantation in Patients With Pure Aortic Regurgitation and Advanced Heart Failure

Anno:

2018

Tipologia prodotto:

Articolo in Rivista

Tipologia ANVUR:

Articolo su rivista

Lingua:

Inglese

Referee:

No

Nome rivista:

American Journal of Cardiology

ISSN Rivista:

0002-9149

N° Volume:

121

Numero o Fascicolo:

5

Intervallo pagine:

642-648

Parole chiave:

Transcatheter Aortic Valve Implantation, Patients With Pure Aortic Regurgitation, Patients With Advanced Heart Failure

Breve descrizione dei contenuti:

Results of transcatheter aortic valve implantation (TAVI) for treatment of severe noncalcific isolated aortic regurgitation (AR) complicated by advanced heart failure or cardiogenic shock has been previously reported only in isolated case reports. Current self-expanding transcatheter aortic valves are designed to treat aortic valve stenosis, and have also been implanted in cases of severe AR due to degenerated bioprosthesis and in very few cases of native aortic valves. We report 13 consecutive inoperable patients with noncalcific, pure AR, and advanced heart failure treated with emergency percutaneous transfemoral implantation with self-expandable CoreValves at our institution between July 2012 and September 2017. The immediate and long-term clinical outcome was prospectively assessed according to the Valve Academic Research Consortium-2 criteria for device success and safety. All but 3 patients had previous surgery of the aortic root, including 2 implants of Heart Mate-II left ventricle assist device; none had surgical aortic bioprosthesis at the time of the TAVI. Valve implantation was successful in 12 of 13 patients (92%) and 1 patient required a second unplanned valve procedure within 18 hours. Oversizing the prosthesis by approximately 15% yielded better results with 1 valve. Two patients with left ventricle assist device died within 30 days of TAVI. All patients who survived to hospital discharge had none or just mild residual AR, improved their cardiac function, and survived at long-term without recurrence of clinical events. In conclusion, implanting self-expandable transcatheter valves in patients pure AR in this small study was safe and effective, and represented an important option for inoperable patients with noncalcific severe AR.

Id prodotto:

101385

Handle IRIS:

11562/974862

ultima modifica:

1 dicembre 2022

Citazione bibliografica:

Pesarini, Gabriele; Lunardi, Mattia; Piccoli, Anna; Gottin, Leonardo; Prati, Daniele; Ferrero, Valeria; Scarsini, Roberto; Milano, Aldo; Forni, Alberto; Faggian, Giuseppe; Ribichini, Flavio, Effectiveness and Safety of Transcatheter Aortic Valve Implantation in Patients With Pure Aortic Regurgitation and Advanced Heart Failure «American Journal of Cardiology» , vol. 121 , n. 5 , 2018 , pp. 642-648

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo